---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-085646"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:40:41.066991+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics receives Nasdaq delisting notice; shares to suspend Mar 5, 2026

## Summary
- Received delisting determination letter on Feb 24, 2026 for failing minimum bid price of $1.00 per share.
- Trading suspension on Nasdaq effective March 5, 2026 unless hearing requested before Nasdaq Hearings Panel.
- Company evaluating appeal and strategic alternatives including possible wind-down or bankruptcy.
- Also noncompliant with $35M minimum market value of listed securities and other listing standards.
- Warns shareholders are unlikely to receive any meaningful distribution in a potential dissolution.

## SEC filing metadata
- accession: 0001193125-26-085646
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000119312526085646/0001193125-26-085646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000119312526085646/itrm-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-085646
- JSON: https://secwatch.observer/filing/0001193125-26-085646.json
- Plain text: https://secwatch.observer/filing/0001193125-26-085646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.